Daily news
Using evidence as the guiding star, the @ducrest Twitter timeline consists of the latest scientific publications in dermatology, cosmetic dermatology, cosmetics and Home-Use devices. Here you will find interesting information gleaned from science and technology sources as well as the lay press.
Photogrammetric Analysis of Attractiveness in Indian Faces. ncbi.nlm.nih.gov/pubmed/2701980… #beauty #BeautyIsPlural
“I have a disorder called #compulsiveskinpicking, so I’m drawing to keep my hands and fingers busy” #skin
RT @ducrest https://t.co/SohfRiHo8e
— Liz Atkin (@LizAtkin) March 29, 2016
RT @ghicdocomo: @MrUrsoBaiarda @ducrest @DrRodRohrich @anneklassen @OlivierBranford @townleywilliam @imcascongress @prsjournal @g https://t…
RT @HealthyLiving: How Apple is getting into personalized medicine huff.to/1UlIrst pic.twitter.com/O94laKs3IC
RT @DrAnjaliMahto: Excellent article from @nytimes The Filler Effect nyti.ms/22DfEAD #skin #aesthetics #dermatology
RT @SkinCancerOrg: Over 5 sunburns doubles your risk of melanoma. Lower your skin cancer risk in 9 steps: skincancer.org/steps https://t…
RT @cebmblog: Why institutions should audit their trial publication record – CEBM cebm.net/institutions-a…
RT @COMPare_Trials: Lessons in Outcome Switching from COMPare: The first blog in the series from @NotDrDalePhD, on the ERASE trial.
https:…
Selective outcome reporting #skincancer. No benefit for patients w/ melanoma undergoing sentinel lymph node biopsy
This is an absolutely damning example of selective outcome reporting in NEJM https://t.co/bWD6zqRQDR
— ben goldacre, MBE LOL (@bengoldacre) March 23, 2016
RT @CebmOxford: Outcome switching, a good example of how science can go wrong. Read about @COMPare_Trials from CEBM @TheEconomist https://t…